Clinical Trial Update: Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating rosuvastatin for prevention of thrombosis in patients with prior venous thrombosis and pulmonary embolism has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Venous Thrombosis, Pulmonary Embolism | Phase 3 | Status: WITHDRAWN